At Pharma Access, our vision is to become the most preferred partner in the Middle East and make a significant contribution to humanity by improving general health of the people in the markets we operate in.

To accomplish this, we collaborate with pharmaceutical and biotech companies aiming to enter the GCC market and achieve top-tier performance in the region. Committed to excellence, we offer fully integrated, customer-focused business solutions to streamline our partners’ pharmaceutical business operations in the GCC, continuously expanding our commercial services and leveraging our unique expertise to maintain a dynamic and progressive growth strategy. For more information about the company, please visit https://www.pharmaaccess.com

About the Janssen Pharmaceutical Companies of Johnson & Johnson:

At Janssen, the Pharmaceutical Companies of Johnson & Johnson, we never stop working to create a future where disease is a thing of the past. We tackle society’s most pressing health challenges, connecting big ideas to the resources we need to make them a reality. Our goal is to advance access to good health for all. By seeking out medical breakthroughs wherever they occur, leveraging internal expertise and embracing external science, we aim to bring the best solutions to the people who need them. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension.

Learn more at www.janssen.com.

Follow us at www.twitter.com/JanssenGlobal.

LILLY BOILERPLATE

Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable.